Issue 8, 2016

Myricetin arrests human telomeric G-quadruplex structure: a new mechanistic approach as an anticancer agent

Abstract

The use of small molecules to arrest G-quadruplex structure has become a potential strategy for the development and design of a new class of anticancer therapeutics. We have studied the interaction of myricetin, a plant flavonoid and a putative anticancer agent, with human telomeric G-quadruplex TTAGGG(TTAGGG)3 DNA. Reverse transcription PCR data revealed significant repression in hTERT expression in MCF-7 breast cancer cells upon increasing the concentration of myricetin. Further, we conducted a telomeric repeat amplification protocol assay to confirm the inhibition of telomerase by myricetin. Optical spectroscopic techniques like circular dichroism, UV spectroscopy and fluorescence spectroscopy revealed the formation of a stable myricetin–G-quadruplex complex. The thermodynamic parameters of myricetin–G-quadruplex complex formation, presented through isothermal titration calorimetry studies, indicate the binding process to be thermodynamically favorable. In addition, high resolution NMR spectroscopy in conjunction with molecular dynamics simulation is employed to provide detailed mechanistic insights into the binding in the myricetin–G-quadruplex complex at the atomic level. Our results thus propose a new mode of action of myricetin as an anticancer agent via arresting telomeric G-quadruplex structure.

Graphical abstract: Myricetin arrests human telomeric G-quadruplex structure: a new mechanistic approach as an anticancer agent

Supplementary files

Article information

Article type
Paper
Submitted
15 جمادى الثانية 1437
Accepted
13 شعبان 1437
First published
13 شعبان 1437

Mol. BioSyst., 2016,12, 2506-2518

Myricetin arrests human telomeric G-quadruplex structure: a new mechanistic approach as an anticancer agent

S. Mondal, J. Jana, P. Sengupta, S. Jana and S. Chatterjee, Mol. BioSyst., 2016, 12, 2506 DOI: 10.1039/C6MB00218H

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements